This type of resistance training may mitigate the chronic inflammatory response in T2DM patients by reducing lymphocyte count in the bloodstream, particularly macrophage activity, resulting in decreased plasma MMP-2 levels. The gene discussed is MMP2; the disease is type 2 diabetes mellitus.